rs536203389

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001379610.1(SPINK1):​c.193C>T​(p.Arg65Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,610,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R65Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

SPINK1
NM_001379610.1 missense, splice_region

Scores

6
12
Splicing: ADA: 0.0005093
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -1.17

Publications

4 publications found
Variant links:
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]
SPINK1 Gene-Disease associations (from GenCC):
  • hereditary chronic pancreatitis
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • tropical pancreatitis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.23813775).
BS2
High AC in GnomAdExome4 at 20 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK1NM_001379610.1 linkc.193C>T p.Arg65Trp missense_variant, splice_region_variant Exon 3 of 4 ENST00000296695.10 NP_001366539.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK1ENST00000296695.10 linkc.193C>T p.Arg65Trp missense_variant, splice_region_variant Exon 3 of 4 1 NM_001379610.1 ENSP00000296695.5 P00995
SPINK1ENST00000510027.2 linkc.193C>T p.Arg65Trp missense_variant Exon 3 of 3 3 ENSP00000427376.1 D6RIU5
SPINK1ENST00000505722.1 linkn.108C>T splice_region_variant, non_coding_transcript_exon_variant Exon 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152024
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000321
AC:
8
AN:
249168
AF XY:
0.0000446
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000548
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000444
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000137
AC:
20
AN:
1458382
Hom.:
0
Cov.:
29
AF XY:
0.0000124
AC XY:
9
AN XY:
725616
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33398
American (AMR)
AF:
0.00
AC:
0
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.0000506
AC:
2
AN:
39522
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85984
European-Finnish (FIN)
AF:
0.0000189
AC:
1
AN:
52880
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000126
AC:
14
AN:
1109876
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
152024
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41402
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Uncertain:2
Nov 03, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R65W variant (also known as c.193C>T), located in coding exon 3 of the SPINK1 gene, results from a C to T substitution at nucleotide position 193. The arginine at codon 65 is replaced by tryptophan, an amino acid with dissimilar properties. This variant was identified in a cohort of normolipemic controls individuals with lipoprotein lipase deficiency; however, specific details were not provided (Tremblay K et al. Front Genet, 2014 Apr;5:90). In HEK293 cells, this variant demonstrated similar mRNA levels compared to wild type (Wu H et al. Genes (Basel), 2017 Oct;8:). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. -

Jan 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 65 of the SPINK1 protein (p.Arg65Trp). This variant is present in population databases (rs536203389, gnomAD 0.005%). This missense change has been observed in individual(s) with chronic pancreatitis (PMID: 33515547). ClinVar contains an entry for this variant (Variation ID: 496198). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jan 27, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The SPINK1 c.193C>T (p.Arg65Trp) variant involves the alteration of a non-conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 1/102932 control chromosomes at a frequency of 0.0000097, which does not exceed the estimated maximal expected allele frequency of a pathogenic SPINK1 variant (0.00025). The variant was reported in a publication in a cohort of healthy and LPL deficiency patients. The variant has not been reported in affected individuals by clinical labs or databases. Taken together, this variant is classified as VUS. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.045
N
LIST_S2
Benign
0.62
T;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.24
T;T
MetaSVM
Benign
-0.67
T
PhyloP100
-1.2
PrimateAI
Benign
0.21
T
PROVEAN
Uncertain
-4.4
D;D
REVEL
Uncertain
0.31
Sift
Uncertain
0.012
D;D
Sift4G
Uncertain
0.016
D;D
Polyphen
0.91
P;.
Vest4
0.35
MutPred
0.62
Loss of disorder (P = 0.0444);Loss of disorder (P = 0.0444);
MVP
0.75
MPC
0.040
ClinPred
0.41
T
GERP RS
-2.2
Varity_R
0.30
gMVP
0.74
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00051
dbscSNV1_RF
Benign
0.20
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs536203389; hg19: chr5-147207586; COSMIC: COSV57024897; API